Ras Isoforms from Lab Benches to Lives-What Are We Missing and How Far Are We?

Arathi Nair1, Katharina F Kubatzky2, Bhaskar Saha1

  • 1National Centre for Cell Science, Ganeshkhind, Pune 411007, India.

Insights

Ras GTPase proteins, crucial in cancer, have distinct functions and locations. Understanding these isoform-specific differences is key to developing targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • Ras GTPase is a central protein in oncogenic pathways, studied for decades.
  • Despite extensive research, gaps remain in understanding Ras function and targeting it therapeutically.
  • Three Ras genes encode four protein isoforms (H-Ras, K-Ras4A, K-Ras4B, N-Ras) with complex roles.

Purpose of the Study:

  • To review the isoform-specific properties of Ras GTPase.
  • To highlight the functional differences between Ras isoforms.
  • To emphasize the importance of isoform-specific properties for future therapeutic strategies.

Main Methods:

  • Literature review of genetic, structural, and functional data on Ras GTPase isoforms.
  • Analysis of emerging data on isoform-specific functions, localization, and effector interactions.
  • Synthesis of information on cell-type, context, and receptor-specific activation.

Main Results:

  • Ras isoforms (H-Ras, K-Ras4A, K-Ras4B, N-Ras) exhibit crucial functional differences, contrary to initial assumptions.
  • Isoforms display cell-type and context-dependent functions, as well as activator and effector specificities.
  • Differential localization of Ras isoforms in cellular microdomains and organelles contributes to distinct signaling pathways.

Conclusions:

  • Recognizing the unique properties of each Ras isoform is essential for advancing cancer therapy.
  • Future therapeutic strategies should leverage isoform-specific differences for greater efficacy and reduced side effects.
  • Further research into Ras isoform biology will unlock new avenues for targeted cancer treatments.

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.7K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
56
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
214
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K